Taste receptors in asthma

Current Opinion in Allergy and Clinical Immunology

Volumn 15, Issue 1, 2015, Pages 63-69

  Grassin Delyle, Stanislas ^a,b   Naline, Emmanuel ^a,b   Devillier, Philippe ^a,b  

^a FOCH HOSPITAL   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

Asthma; bitter taste receptors; lung

Indexed keywords

AZELASTINE; CAFFEINE; CHLOROQUINE; CHLORPHENIRAMINE; COLCHICINE; ERYTHROMYCIN; ANTIASTHMATIC AGENT; AUTACOID; G PROTEIN COUPLED RECEPTOR; TASTE RECEPTORS, TYPE 2;

AIRWAY CONDUCTANCE; AIRWAY RESISTANCE; ASTHMA; BITTER TASTE; BRONCHUS REACTIVITY; BRUSH BORDER; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS MACROPHAGE; LUNG FUNCTION; MUCOCILIARY CLEARANCE; NONHUMAN; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; REVIEW; TASTE BUD; AGONISTS; ANIMAL; DISEASE MODEL; IMMUNOLOGY; LUNG; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION MEDIATORS; LUNG; MOLECULAR TARGETED THERAPY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84920869681     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0000000000000137     Document Type: Review

References (55)

1. Martinez FD, Vercelli D. Asthma. Lancet 2013; 382:1360-1372.
2. Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008; 178:218-224.
3. Demoly P, Annunziata K, Gubba E, Adamek L. Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years. Eur Respir Rev 2012; 21:66-74.
4. Chapman KR, Boulet LP, Rea RM, Franssen E. Suboptimal asthma control: prevalence, detection and consequences in general practice. Eur Respir J 2008; 31:320-325.
5. Global Initiative for Asthma. Global strategy for asthma managment and prevention. Update 2014. http://www.ginasthma.org/local/uploads/files/GI-NA-Report-2014-Aug12.pdf. [Accessed 24 September 2014]
6. Deshpande DA, Wang WC, McIlmoyle EL, et al. Bitter taste receptors on airway smooth muscle bronchodilate by localized calcium signaling and reverse obstruction. Nat Med 2010; 16:1299-1304.
7. Shah AS, Ben-Shahar Y, Moninger TO, et al. Motile cilia of human airway epithelia are chemosensory. Science 2009; 325:1131-1134.
8. Grassin-Delyle S, Abrial C, Fayad-Kobeissi S, et al. The expression and relaxant effect of bitter taste receptors in human bronchi. Respir Res 2013; 14:134.
9. Robinett KS, Koziol-White CJ, Akoluk A, et al. Bitter taste receptor function in asthmatic and nonasthmatic human airway smooth muscle cells. Am J Respir Cell Mol Biol 2014; 50:678-683.
10. Ekoff M, Choi JH, James A, et al. Bitter taste receptor (TAS2R) agonists inhibit IgE-dependent mast cell activation. J Allergy Clin Immunol 2014; 134:475-478.
11. Orsmark-Pietras C, James A, Konradsen JR, et al. Transcriptome analysis reveals upregulation of bitter taste receptors in severe asthmatics. Eur Respir J 2013; 42:65-78.
12. Bukowskyj M, Nakatsu K. The bronchodilator effect of caffeine in adult asthmatics. Am Rev Respir Dis 1987; 135:173-175.
13. Gong H Jr, Simmons MS, Tashkin DP, et al. Bronchodilator effects of caffeine in coffee. A dose-response study of asthmatic subjects. Chest 1986; 89:335-342.
14. Becker AB, Simons KJ, Gillespie CA, Simons FE. The bronchodilator effects and pharmacokinetics of caffeine in asthma. N Engl J Med 1984; 310:743-746.
15. Kivity S, Ben Aharon Y, Man A, Topilsky M. The effect of caffeine on exercise-induced bronchoconstriction. Chest 1990; 97:1083-1085.
16. Colacone A, Bertolo L, Wolkove N, et al. Effect of caffeine on histamine bronchoprovocation in asthma. Thorax 1990; 45:630-632.
17. Henderson JC, O'Connell F, Fuller RW. Decrease of histamine induced bronchoconstriction by caffeine in mild asthma. Thorax 1993; 48:824-826.
18. Miyatake H, Taki F, Taniguchi H, et al. Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma. Chest 1991; 99:670-673.
19. Popa VT. Bronchodilating activity of an H1 blocker, chlorpheniramine. J Allergy Clin Immunol 1977; 59:54-63.
20. Ollier S, Gould CA, Davies RJ. The effect of single and multiple dose therapy with azelastine on the immediate asthmatic response to allergen provocation testing. J Allergy Clin Immunol 1986; 78:358-364.
21. Albazzaz MK, Patel KR. Effect of azelastine on bronchoconstriction induced by histamine and leukotriene C4 in patients with extrinsic asthma. Thorax 1988; 43:306-311.
22. Rafferty P, Holgate ST. The inhibitory effect of azelastine hydrochloride on histamine-and allergen-induced bronchoconstriction in atopic asthma. Clin Exp Allergy 1989; 19:315-320.
23. Kelly SJ, Uri AJ, Freeland HS, et al. Effects of colchicine on IgE-mediated early and late airway reactions. Chest 1995; 107:985-991.
24. Fish JE, Peters SP, Chambers CV, et al. An evaluation of colchicine as an alternative to inhaled corticosteroids in moderate asthma. National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Am J Respir Crit Care Med 1997; 156:1165-1171.
25. Charous BL. Open study of hydroxychloroquine in the treatment of severe symptomatic or corticosteroid-dependent asthma. Ann Allergy 1990; 65:53-58.
26. Charous BL, Halpern EF, Steven GC. Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma. J Allergy Clin Immunol 1998; 102:198-203.
27. Andres-Barquin PJ, Conte C. Molecular basis of bitter taste: the T2R family of G protein-coupled receptors. Cell Biochem Biophys 2004; 41:99-112.
28. Chandrashekar J, Hoon MA, Ryba NJ, Zuker CS. The receptors and cells for mammalian taste. Nature 2006; 444:288-294.
29. Manson ML, Safholm J, Al-Ameri M, et al. Bitter taste receptor agonists mediate relaxation of human and rodent vascular smooth muscle. Eur J Pharmacol 2014; 740C:302-311.
30. Kim KS, Egan JM, Jang HJ. Denatonium induces secretion of glucagon-like peptide-1 through activation of bitter taste receptor pathways. Diabetologia 2014; 57:2117-2125.
31. Foster SR, Blank K, See Hoe LE, et al. Bitter taste receptor agonists elicit G-protein-dependent negative inotropy in the murine heart. FASEB J 2014; 28:4497-4508.
32. Meyerhof W, Batram C, Kuhn C, et al. The molecular receptive ranges of human TAS2R bitter taste receptors. Chem Senses 2010; 35:157-170.
33. Tizzano M, Gulbransen BD, Vandenbeuch A, et al. Nasal chemosensory cells use bitter taste signaling to detect irritants and bacterial signals. Proc Natl Acad Sci USA 2010; 107:3210-3215.
34. Lee RJ, Xiong G, Kofonow JM, et al. T2R38 taste receptor polymorphisms underlie susceptibility to upper respiratory infection. J Clin Invest 2012; 122:4145-4159.
35. Thomas B, Rutman A, Hirst RA, et al. Ciliary dysfunction and ultrastructural abnormalities are features of severe asthma. J Allergy Clin Immunol 2010; 126:722-729; e722.
36. Pulkkinen V, Manson ML, Safholm J, et al. The bitter taste receptor (TAS2R) agonists denatonium and chloroquine display distinct patterns of relaxation of the guinea pig trachea. Am J Physiol Lung Cell Mol Physiol 2012; 303:L956-L966.
37. Belvisi MG, Dale N, Birrell MA, Canning BJ. Bronchodilator activity of bitter tastants in human tissue. Nat Med 2011; 17:776; Author reply 776-778.
38. Morice AH, Bennett RT, Chaudhry MA, et al. Effect of bitter tastants on human bronchi. Nat Med 2011; 17:775.
39. Panebra A, Hershfeld A, Deshpande DA. Bitter taste receptor (BTR) agonists inhibit mitogenic signaling in human airway smooth muscle (ASM) cells. Am J Respir Crit Care Med 2014; 189 Abstracts Issue: A1047-A1047.
40. Grassin-Delyle S, Abrial C, Brollo M, et al. Characterization of the expression and the role of bitter taste receptors in human lung parenchyma and macro-phages. Am J Respir Crit Care Med 2014; 189 Abstracts Issue: A5749-A5749.
41. Jang CH, Choi JH, Byun MS, Jue DM. Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes. Rheumatology (Oxford) 2006; 45:703-710.
42. Cosmetic Ingredient Review Expert P. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate. Int J Toxicol 2008; 27 (Suppl 1):1-43.
43. Krasteva G, Canning BJ, Hartmann P, et al. Cholinergic chemosensory cells in the trachea regulate breathing. Proc Natl Acad Sci USA 2011; 108:9478-9483.
44. Weichelt U, Cay R, Schmitz T, et al. Prevention of hyperoxia-mediated pulmonary inflammation in neonatal rats by caffeine. Eur Respir J 2013; 41:966-973.
45. Kanoh S, Tanabe T, Rubin BK. Dapsone inhibits IL-8 secretion from human bronchial epithelial cells stimulated with lipopolysaccharide and resolves airway inflammation in the ferret. Chest 2011; 140:980-990.
46. Ghio A, Lehmann J, Winsett D, et al. Colchicine decreases airway hyper-reactivity after phosgene exposure. Inhal Toxicol 2005; 17:277-285.
47. Sanz MJ, Nabah YN, Cerda-Nicolas M, et al. Erythromycin exerts in vivo anti-inflammatory activity downregulating cell adhesion molecule expression. Br J Pharmacol 2005; 144:190-201.
48. Welsh EJ, Bara A, Barley E, Cates CJ. Caffeine for asthma. Cochrane Database Syst Rev 2010; 1:CD001112.
49. Matera MG, Tufano MA, Polverino M, et al. Pulmonary concentrations of dirithromycin and erythromycin during acute exacerbation of mild chronic obstructive pulmonary disease. Eur Respir J 1997; 10:98-103.
50. Brun Y, Forey F, Gamondes JP, et al. Levels of erythromycin in pulmonary tissue and bronchial mucus compared to those of amoxycillin. J Antimicrob Chemother 1981; 8:459-466.
51. Wollmer P, Pride NB, Rhodes CG, et al. Measurement of pulmonary ery-thromycin concentration in patients with lobar pneumonia by means of positron tomography. Lancet 1982; 2:1361-1364.
52. Chand N, Adusumalli VE, Nolan K, et al. Pharmacodynamic and pharmaco-kinetic studies with azelastine in the guinea pig: evidence for preferential distribution into the lung. Allergy 1993; 48:19-24.
53. Rochdi M, Sabouraud A, Baud FJ, et al. Toxicokinetics of colchicine in humans: analysis of tissue, plasma and urine data in ten cases. Hum Exp Toxicol 1992; 11:510-516.
54. Ben-Chetrit E, Bergmann S, Sood R. Mechanism of the anti-inflammatory effect of colchicine in rheumatic diseases: a possible new outlook through microarray analysis. Rheumatology (Oxford) 2006; 45:274-282.
55. Baltzan M, Mehta S, Kirkham TH, Cosio MG. Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis. Am J Respir Crit Care Med 1999; 160:192-197.